Reaffirms guidance to resubmit Anaphylm™ (dibutepinephrine) sublingual film NDA in Q3 2026; Type A meeting with FDA expected to occur within 30 ...
Webull Corporation (NASDAQ: BULL) ("Webull" or the "Company") today announced financial and operating results for the fourth ...
REDMOND, WASHINGTON / ACCESS Newswire / March 4, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its fourth quarter and full y ...
Company marks first full year as public company with record revenue of $571 million and record net deposits of $8.6 billion, representing a 46% and 91% increase respectively Webull will continue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results